How many institutions held CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in Q3 2022?

61 institutional investors reported CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share for Q3 2022. Use the holders table for investor-level position and value details.

Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

Q: What does CUSIP 22978P106 represent in this 13F holders report?

CUSIP 22978P106 is the security identifier for CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 22978P106

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 43,411,663
Total 13F shares: 12,797,287
Share change: -1,294,090
Total reported value: $28,665,093
Put/Call ratio: 0%
Price per share: $2.23
Number of holders: 61
Value change: -$2,995,285
Number of buys: 15
Number of sells: 41

Quarterly Holders Quick Answers

What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 22978P106:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Prosight Management, LP	13F	Company	3.8%	1,655,477	$4,122,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	3.5%	1,522,319	$3,791,000	—	30 Jun 2022	13F
Slate Path Capital LP	13F	Company	3.4%	1,483,619	$3,694,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	1.9%	831,925	$2,072,000	—	30 Jun 2022	13F
Cameron Gray	3/4/5	Director	— class O/S missing	687,049	$1,896,255	—	14 Jun 2022	3/4/5
SANDERS MORRIS HARRIS LLC	13F	Company	1.7%	736,212	$1,803,000	—	30 Jun 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.5%	668,634	$1,666,000	—	30 Jun 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.4%	602,205	$1,499,000	—	30 Jun 2022	13F
Carlson Capital, L.P.	13F	Company	1.3%	580,000	$1,444,000	—	30 Jun 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.3%	579,700	$1,443,000	—	30 Jun 2022	13F
Bleichroeder LP	13F	Company	1.3%	555,000	$1,382,000	—	30 Jun 2022	13F
Robertson Stephens Wealth Management, LLC	13F	Company	1.1%	478,500	$1,191,000	—	30 Jun 2022	13F
Monaco Asset Management SAM	13F	Company	1%	443,851	$1,105,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	1%	435,402	$1,085,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.69%	298,072	$742,000	—	30 Jun 2022	13F
ADVISORY RESEARCH INC	13F	Company	0.59%	257,225	$640,000	—	30 Jun 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.49%	214,100	$533,000	—	30 Jun 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.47%	204,043	$508,000	—	30 Jun 2022	13F
P.A.W. CAPITAL CORP	13F	Company	0.4%	175,000	$436,000	—	30 Jun 2022	13F
Sigma Planning Corp	13F	Company	0.38%	167,106	$416,000	—	30 Jun 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.38%	165,011	$411,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	0.37%	158,604	$395,000	—	30 Jun 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.35%	150,205	$374,000	—	30 Jun 2022	13F
Ergoteles LLC	13F	Company	0.31%	136,400	$340,000	—	30 Jun 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.3%	130,854	$326,000	—	30 Jun 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.3%	129,666	$323,000	—	30 Jun 2022	13F
APOGEM CAPITAL LLC	13F	Company	0.28%	123,148	$307,000	—	30 Jun 2022	13F
Nantahala Capital Management, LLC	13F	Company	0.23%	100,464	$250,000	—	30 Jun 2022	13F
Voss Capital, LP	13F	Company	0.23%	100,000	$249,000	—	30 Jun 2022	13F
Parallax Volatility Advisers, L.P.	13F	Company	0.17%	75,000	$187,000	—	30 Jun 2022	13F
STIFEL FINANCIAL CORP	13F	Company	0.15%	66,656	$165,000	—	30 Jun 2022	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.15%	66,135	$165,000	—	30 Jun 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.14%	62,163	$155,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	0.14%	60,474	$150,000	—	30 Jun 2022	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.14%	59,662	$149,000	—	30 Jun 2022	13F
Good Life Advisors, LLC	13F	Company	0.13%	57,000	$142,000	—	30 Jun 2022	13F
MARSHALL WACE, LLP	13F	Company	0.12%	53,971	$134,000	—	30 Jun 2022	13F
RBF Capital, LLC	13F	Company	0.09%	40,000	$100,000	—	30 Jun 2022	13F
XTX Topco Ltd	13F	Company	0.09%	38,843	$97,000	—	30 Jun 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	0.09%	38,700	$96,000	—	30 Jun 2022	13F
Jump Financial, LLC	13F	Company	0.08%	35,296	$88,000	—	30 Jun 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.07%	31,064	$77,000	—	30 Jun 2022	13F
UBS Group AG	13F	Company	0.07%	28,421	$71,000	—	30 Jun 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.06%	26,300	$65,000	—	30 Jun 2022	13F
Bank of New York Mellon Corp	13F	Company	0.05%	21,329	$53,000	—	30 Jun 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.05%	19,990	$50,000	—	30 Jun 2022	13F
Bridgefront Capital, LLC	13F	Company	0.05%	19,968	$50,000	—	30 Jun 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.04%	17,960	$45,000	—	30 Jun 2022	13F
SIMPLEX TRADING, LLC	13F	Company	0.04%	17,820	$44,000	—	30 Jun 2022	13F
Engineers Gate Manager LP	13F	Company	0.04%	17,260	$43,000	—	30 Jun 2022	13F

Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2022

As of 30 Sep 2022, Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,797,287 shares. The largest 10 holders included Prosight Management, LP, VANGUARD GROUP INC, Slate Path Capital LP, SANDERS MORRIS HARRIS LLC, BlackRock Inc., Bleichroeder LP, CARLSON CAPITAL L P, Robertson Stephens Wealth Management, LLC, Monaco Asset Management SAM, and DIMENSIONAL FUND ADVISORS LP. This page lists 61 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

-7

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.